Intellipharmaceutics International Inc. (IPCI)

[wimuskyfisherman]

mopar and doog- With the number of subjects like 30, 40 or 50 for each category 3 test my gut tells me it won't be outrageously expensive. It sounds like the company is going to work with the FDA on what they need to do and then do it. Like I said, this is not a timeline hit as I expected Rexista to hit market in 2018 or 2019. Its just a cost thing.